Skip to Navigation
Skip to Content

NCSD Annual Meeting

Save the Date:  NCSD's 2014 Annual Meeting, October 28-31, 2014, Washington, DC

The National Coalition of STD Director’s Annual Meeting provides attendees with the opportunity to network and share effective STD and HIV prevention strategies for a variety of populations.  This yearly meeting is the only annual meeting for the key STD leads in state and local health departments and the only annual meeting in the country where STDs are the primary focus.

The main purpose of the meeting is to provide participants with meaningful information and practical insights regarding STD prevention and control.  For example, the 2011 agenda provided an opportunity for NCSD members and colleagues to focus awareness in the areas of Public Health and the Impacts of Health Care Reform, Social Determinants of Health, Third Party Billing, STD Prevention Among Special Populations, The National AIDS Strategy, as well as many other important topics within the field of STD prevention.

The average attendance is an audience of approximately 200 individuals, primarily including NCSD members from project areas across the United States, public health partner organizations, staff of the CDC Division of STD Prevention, as well as corporate exhibitors. 

Please click on the links below for more information regarding upcoming and past meetings.

 

NCSD's 2013 Annual Meeting, November 12-15, 2013, Albuquerque, NM
NCSD's 2012 Annual Meeting, October 9-12, 2012, Washington, DC
NCSD's 2011 Annual Meeting
Past Annual Meetings

Highlighted Resources

The National Coalition for Sexual Health (NCSH) is pleased to announce the release of a new, easy-to-use guide and website, Take Charge of Your Sexual Health: What you nee

Read more...

On December 19th, 2013, the American Sexual Health Association (ASHA) and the National Coalition of STD Directors (NCSD) convened a small group of stakeholders from the policy, research, cancer, healthcare provider and sexual health fields to discuss potential policy actions to facilitate HPV/Pap co-testing, and adherence to screening guidelines.

Read more...